Navigation Links
Eclipsys Sunrise Acute Care Receives CCHIT Certification
Date:11/5/2007

- Software Meets 100 Percent of Newly Launched Inpatient Certification

Criteria -

ATLANTA, Nov. 5 /PRNewswire-FirstCall/ -- The Certification Commission for Healthcare Information Technology (CCHIT(sm)) today announced that the Eclypsis Corporation(R) (Nasdaq: ECLP), The Outcomes Company(R), product Sunrise Acute Care(TM) 4.5 SP 4, a module of Sunrise Clinical Manager(TM), is CCHIT Certified(sm), and meets the Commission's newly launched inpatient electronic health record (EHR) criteria for 2007. Inpatient EHRs are designed for use in acute care hospitals. The Commission -- an independent, nonprofit organization -- is the Recognized Certification Body in the United States for certifying health information technology products.

(Logo: http://www.newscom.com/cgi-bin/prnh/20050209/FLW006LOGO )

In addition to meeting foundation standards such as security, certified inpatient products are examined for clinician order entry (often called CPOE) and medication administration capabilities (often called eMAR), including related clinical decision support. As a CCHIT Certified product, Sunrise Acute Care 4.5 has been tested and passed inspection of 100 percent of a set of criteria for CPOE and eMAR. The Commission focused certification testing on these areas first because they have the lowest rate of adoption in hospitals but are thought to offer the highest value for improvement of care.

"Eclipsys has long been a leader in CPOE, as our Knowledge-Based CPOE(TM) system is the most widely used in the industry, and we are very excited that Sunrise Acute Care is one of the first products to pass such a thorough evaluation for CPOE as well as eMAR," said Bob Elson, MD, Eclipsys chief medical officer. "We share the same belief as the Commission that CPOE is one of the most important ways for a healthcare organization to improve care delivery, which is why we are committed to helping our clients achieve high levels of CPOE adoption."

Since it first announced certifications for ambulatory EHR software products in July of 2006, the Commission has raised the bar for ambulatory EHRs and expanded its certification scope to the inpatient care setting.

"We're very proud of achieving CCHIT certification for Sunrise Acute Care given the rigor of testing the Commission required in this first inpatient round," said Jay Deady, Eclipsys executive vice president, Client Solutions. "Unlike many of our competitors, Eclipsys clinical solutions have an integrated advanced rules engine and are all on the same integrated Eclipsys XA architecture. We believe this is vital to meet the increasingly challenging requirements of the Commission for both the acute and ambulatory environments."

"The thorough inspection process ensures that certified products have demonstrated their ability to have a positive impact on the quality and safety of patient care," said Mark Leavitt, M.D., Ph.D., chair of the Commission. "I'd like to congratulate the first round of certified product companies, who now represent the leading edge in advanced EHR products for the inpatient setting."

The CCHIT Certified mark -- a "seal of approval" for EHR products -- provides the first consensus-based, government-recognized benchmark for inpatient EHR products. By looking to products with the CCHIT Certified seal, acute care providers can reduce their risk in selecting EHR products for CPOE and eMAR.

CCHIT's certification compliance criteria and its design for a certification inspection process have been thoroughly researched, taking into account the state of the art of EHRs and available standards, and comparing certification processes in other industries and other countries. The inspection process is based on real-life medical scenarios designed to test products rigorously against the clinical needs of providers and the quality and safety needs of healthcare consumers and payers. One script, for example, recreates a scenario of a middle-aged man admitted through the emergency department after sustaining fractures in an automobile accident. The script tests the ability of the EHR to provide clinical decision support during the ordering and administration of medications, and to track whether laboratory and radiology orders have been entered and received.

About Eclipsys

Eclipsys is a leading provider of advanced integrated clinical, revenue cycle and access management software, clinical content and professional services that help healthcare organizations improve clinical, financial, operational and client satisfaction outcomes. For more information, see http://www.eclipsys.com or email info@eclipsys.com.

About CCHIT

The Certification Commission for Healthcare Information Technology (CCHIT(sm)) is an independent, nonprofit organization that has been named by the federal government as the Recognized Certification Body for health information technology. Its mission is to accelerate the adoption of health information technology by creating a credible, sustainable certification program. The certification requirements are based on widely accepted industry standards and involve the work of hundreds of expert volunteers and input from a variety of stakeholders throughout the health care industry. More information on CCHIT and CCHIT Certified(sm) products is available at http://www.cchit.org.

Statements in this news release concerning the benefits that may be provided Eclipsys software or by CCHIT's certification of such software are forward-looking statements and actual results may differ from those projected due to a variety of risks and uncertainties. Results depend upon a variety of factors and can vary by client. Each client's circumstances are unique and may include unforeseen issues that make it more difficult than anticipated to implement or derive benefit from software or services. The success and timeliness of the company's services often depends at least in part upon client involvement, which can be difficult to control. More information about company risks is available in recent Form 10-Q and 10-K filings made by Eclipsys from time to time with the Securities and Exchange Commission. Special attention is directed to the portions of those documents entitled "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations." Eclipsys Corporation and The Outcomes Company are registered trademarks of Eclipsys Corporation. Sunrise Clinical Manager and Sunrise Acute Care are trademarks of Eclipsys Corporation. Other product and company names in this news release are trademarks and/or registered trademarks of their respective companies.

Eclipsys

Jason Cigarran

Director of Media Relations (media)

(561) 322-4355

jason.cigarran@eclipsys.com

Robert J. Colletti

Chief Financial Officer (investors)

(561) 322-4655

investor.relations@eclipsys.com

CCHIT

Sue Reber

503-703-0813

sreber@cchit.org


'/>"/>
SOURCE Eclipsys Corporation
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Eclipsys Knowledge-Based Charting Helps Health First Improve Patient-Care Outcomes
2. Eclipsys User Network Brings Eclipsys Clients Together to Share Outcome Improvement Strategies
3. SingHealth Selects Eclipsys Solutions to Help Improve Clinical Outcomes, First Sunrise Clinical Manager Client Outside of North America
4. Eclipsys Announces Relocation of Corporate Headquarters to Atlanta, GA
5. Sunrise Provides Status Report on Special Independent Committee Investigation; Provides Updates on Managements Internal Control Review Efforts and on Legal Proceedings
6. Sunrise Settles Litigation Regarding Its 2007 Annual Meeting
7. Diabetes appears to increase risk of death for patients with acute coronary syndromes
8. Keane Wins $1 Million Electronic Medical Record (EMR) Implementation at New Jersey-Based Acute Care Facility
9. Study shows insurance status, not race, linked to complications in patients with acute appendicitis
10. FDA Approves LEVAQUIN(R) Short-Course Therapy for Treatment of Complicated Urinary Tract Infections and Acute Pyelonephritis
11. Acute lung injury patients one-third less likely to die in closed model ICUs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... NY & Salt Lake City, UT (PRWEB) , ... February 05, ... ... Founder of Activz Whole-Food Nutrition , announced that the much-anticipated feature with author ... the New Really Cool Humans Amateur TV Network. , Each week, on his weekly ...
(Date:2/5/2016)... ... February 05, 2016 , ... The event is being held ... Event Center in Minneapolis, Minn. Triumph Over Parkinson’s will fund nearly $100,000 for research ... Schneiderman’s Furniture, lives with Parkinson’s disease and is the architect of this informative event ...
(Date:2/5/2016)... ... February 05, 2016 , ... ... addition of micro-needling services in their Napa Valley office. The technique utilizes the ... Surgery Associates, Dr. Canales and Dr. Furnas, are part of only a select ...
(Date:2/5/2016)... ... February 05, 2016 , ... ... H. Van Allen have signed a joint enrollment and degree completion agreement. ... toward associate and baccalaureate degrees at FHU|Dickson. , The agreement allows students ...
(Date:2/5/2016)... ... February 05, 2016 , ... ... exclusively to funding innovative lymphoma research and serving the lymphoma community through a ... to once again host, Swirl, A Wine Tasting Event at the La Gorce ...
Breaking Medicine News(10 mins):
(Date:2/4/2016)... , Feb. 4, 2016 Summary Breast ... cancer and the most common cancer in women worldwide, ... disease exceedingly prevalent. The number of women diagnosed with ... but the number of deaths has declined due to ... treatment has been revolutionized in the past four decades, ...
(Date:2/4/2016)... Feb. 4, 2016 Mettler-Toledo International Inc. (NYSE: ... 2015.  Provided below are the highlights: , ... compared with the prior year.  Reported sales decreased 3% ... quarter. , Net earnings per diluted share as ... prior- year period.  Adjusted EPS was $4.65, an increase ...
(Date:2/4/2016)... 2016  Blueprint Medicines Corporation (NASDAQ: BPMC ... selective investigational kinase medicines for patients with genomically ... board of directors of Lonnel Coats , ... of industry-related experience. Jeffrey Albers ... strong strategic experience developing and commercializing numerous oncology ...
Breaking Medicine Technology: